Central Eastern Europe injection lipolysis topical products market is projected to register a substantial CAGR of 9.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029. Market Segmentation: Central Eastern Europe Injection Lipolysis Topical Products Market, By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat Deposits, Buttock Fat, Knee Fat, Others), Gender (Female, Male), End-User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Countries (Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest of Central Europe) - Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Central Eastern Europe injection lipolysis topical products market are:
Growing prevalence of diabetes, obesity Growing awareness towards the fat reduction procedures Market Segmentation: Central Eastern Europe Injection Lipolysis Topical Products Market is categorized into four notable segments, which are the area of application, gender, distribution channel, and end-user.
On the basis of area of application, the market is segmented into abdominal fat, thighs fat, upper arm fat, facial fat deposits, buttock fat, knee fat, others On the basis of gender, the market is segmented into female and male On the basis of end-user, the market is segmented into ambulatory surgical centers (ASCS), clinics, hospitals, others On the basis of distribution channel, the market is segmented into direct tender, retail sales, others
Market Players:
The key market players operating in the Central Eastern Europe injection lipolysis topical products market are listed below:
Abbvie Leaderma Inc. Marllor Biomedical Srl Mesosystem Laboratorio Innoaesthetics, S.L.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 OVERVIEW OF CENTRAL EASTERN EUROPE INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET 49
1.4 LIMITATIONS 50
1.5 MARKETS COVERED 51
2 MARKET SEGMENTATION 53
2.1 MARKETS COVERED 53
2.2 GEOGRAPHICAL SCOPE 54
2.3 YEARS CONSIDERED FOR THE STUDY 55
2.4 CURRENCY AND PRICING 55
2.5 DBMR TRIPOD DATA VALIDATION MODEL 56
2.6 AREA OF APPLICATION LIFELINE CURVE 59
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.8 DBMR MARKET POSITION GRID 61
2.9 MARKET APPLICATION COVERAGE GRID 62
2.10 VENDOR SHARE ANALYSIS 63
2.11 SECONDARY SOURCES 64
2.12 ASSUMPTIONS 64
3 EXECUTIVE SUMMARY 65
4 PREMIUM INSIGHTS 68
4.1 PESTEL ANALYSIS 69
4.2 PORTERS FIVE FORCES 70
5 EPIDEMIOLOGY 71
5.1 INCIDENCE RATE OF ALL 71
5.2 TREATMENT RATE 71
5.3 MORTALITY RATE 72
5.4 PATIENT TREATMENT SUCCESS RATES 72
6 INDUSTRY INSIGHT 73
6.1 PATENT ANALYSIS 73
6.2 KEY PRICING STRATEGY 73
6.3 KEY PATIENT ENROLLMENT STRATEGY 73
6.4 POST SURGERY COMPLICATION 74
7 PIPELINE ANALYSIS 76
7.1 PATIENT TREATMENT SUCCESS RATES 76
8 REGIONAL ANALYSIS 77
9 CENTRAL EASTERN EUROPE INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET: REGULATIONS 79
9.1 REGULATION IN EUROPE 80
10 CENTRAL EASTERN EUROPE INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET, COUNTRY 81
10.1 GERMANY 97
10.2 UNITED KINGDOM 107
10.3 FRANCE 117
10.4 NETHERLANDS 127
10.5 SWITERZERLAND 137
10.6 POLAND 147
10.7 BELGIUM 157
10.8 IRELAND 167
10.9 AUSTRIA 177
10.10 ROMANIA 187
10.11 CZECH REPUBLIC 197
10.12 HUNGARY 207
10.13 SLOVAKIA 217
10.14 LUXEMBOURG 227
10.15 SLOVENIA 237
10.16 LIECHTENSTEIN 247
10.17 REST OF CENTRAL EUROPE 257
11 CENTRAL EASTERN EUROPE INJECTION LIPOLYSIS TOPICAL PRODUCTS MARKET: COMPANY LANDSCAPE 258
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 258
12 COMPANY PROFILE 259
12.1 ABBVIE INC 259
12.1.1 COMPANY SNAPSHOT 259
12.1.2 REVENUE ANALYSIS 259
12.1.3 PRODUCT PORTFOLIO 260
12.1.4 RECENT DEVELOPMENTS 260
12.2 LEADERMA, INC 261
12.2.1 COMPANY SNAPSHOT 261
12.2.2 PRODUCT PORTFOLIO 261
12.2.3 RECENT DEVELOPMENT 261
12.3 MARLLOR BIOMEDICAL SRL 262
12.3.1 COMPANY SNAPSHOT 262
12.3.2 PRODUCT PORTFOLIO 262
12.3.3 RECENT DEVELOPMENT 262
12.4 MESOSYSTEMS 263
12.4.1 COMPANY SNAPSHOT 263
12.4.2 PRODUCT PORTFOLIO 263
12.4.3 RECENT DEVELOPMENT 263
12.5 SIMILDIET S.L 264
12.5.1 COMPANY SNAPSHOT 264
12.5.2 PRODUCT PORTFOLIO 264
12.5.3 RECENT DEVELOPMENT 264
12.6 MESOMEDICA 265
12.6.1 COMPANY SNAPSHOT 265
12.6.2 PRODUCT PORTFOLIO 265
12.6.3 RECENT DEVELOPMENT 265
12.7 REXPHARMA 266
12.7.1 COMPANY SNAPSHOT 266
12.7.2 PRODUCT PORTFOLIO 266
12.7.3 RECENT DEVELOPMENT 266
12.8 SANOFI 267
12.8.1 COMPANY SNAPSHOT 267
12.8.2 REVENUE ANALYSIS 267
12.8.3 PRODUCT PORTFOLIO 268
12.8.4 RECENT DEVELOPMENTS 268
13 QUESTIONNAIRE 269
14 RELATED REPORTS 271
Segmentation
Short Description
Central Eastern Europe Injection Lipolysis Topical Products Market, By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat, Buttock Fat, Knee Fat), Gender (Male and Female), End User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, and others) Distribution Channel (Direct Tender, Retail Sales and Others), Countries (Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest Of Central Europe) Industry Trends & Forecast to 2029.
Market Definition:
Injection lipolysis chemically reduces the number of fat cells around the injection site. The chemical, called deoxycholic acid, results in fat cell disruption and death. Injection lipolysis is a commonly encountered entity in dermatology practice and is a non-surgical procedure.
The demand for injection lipolysis topical products has increased in developed and developing countries. This is the increasing prevalence of eye disorders and product launches. The injection lipolysis topical products market is growing due to introduction of innovative products, increasing technological products, and rising disposable income. The market will grow in the forecasted period due to exploring emerging markets, strategic initiatives by market players, and increasing healthcare expenditure.
Market Segmentation:
Central Eastern Europe injection lipolysis topical products market is categorized into four notable segments: application, gender, end-user, and distribution channel.
On the basis of devices, the Central Eastern Europe injection lipolysis topical products market is segmented into abdominal fat, thighs fat, upper arm fat, facial fat, buttock fat, and knee fat. In 2022, the abdominal fat segment is expected to dominate the Central Eastern Europe injection lipolysis topical products market due to the increased prevalence of obesity and diabetes in males and females
On the basis of gender, the Central Eastern Europe injection lipolysis topical products market is segmented into females and males. In 2022, female is expected to dominate the Central Eastern Europe injection lipolysis topical products market with the increasingly advanced technology and rising strategic initiatives by major market players
On the basis of end-user, the Central Eastern Europe injection lipolysis topical products market is segmented into hospitals, clinics, ambulatory surgical centers (ASCS), and others. In 2022, the hospital segment is expected to dominate the Central Eastern Europe injection lipolysis topical products market with the increasing number of patients and surgeries
On the basis of distribution channel, the Central Eastern Europe injection lipolysis topical products market is segmented into direct tender, retail sales, and others. In 2022, direct tender is expected to dominate the Central Eastern Europe injection lipolysis topical products market with a wide range of products available through this distribution channel.
Market Players
The key market players for Central Eastern Europe injection lipolysis topical products market are listed below:
